Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2014

Open Access 01-12-2014 | Research article

Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo

Authors: Berna Kankilic, Elif Bilgic, Petek Korkusuz, Feza Korkusuz

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2014

Login to get access

Abstract

Background

Implant-related osteomyelitis (IRO) is recently controlled with local antibiotic delivery systems to overcome conventional therapy disadvantages. In vivo evaluation of such systems is however too little.

Questions/purposes

We asked whether vancomycin (V)-containing poly-l-lactic acid/β-tricalcium phosphate (PLLA/β-TCP) composites control experimental IRO and promote bone healing in vivo.

Methods

Fifty-six rats were distributed to five groups in this longitudinal controlled study. Experimental IRO was established at tibiae by injecting methicillin-resistant Staphylococcus aureus (MRSA) suspensions with titanium particles in 32 rats. Vancomycin-free PLLA/β-TCP composites were implanted into the normal and infected tibiae, whereas V-PLLA/β-TCP composites and coated (C)-V-PLLA/β-TCP composites were implanted into IRO sites. Sham-operated tibiae established the control group. Radiological and histological scores were quantified with microbiological findings on weeks 1 and 6.

Results

IRO is resolved in the CV- and the V-PLLA/β-TCP groups but not in the PLLA/β-TCP group. MRSA was not isolated in the CV- and the V-PLLA/β-TCP groups at all times whereas the bacteria were present in the PLLA/β-TCP group. Radiological signs secondary to infection are improved from 10.9 ± 0.9 to 3.0 ± 0.3 in the V-PLLA/β-TCP group but remained constant in the PLLA/β-TCP group. Histology scores are improved from 24.7 ± 6.5 to 17.6 ± 4.8 and from 27.6 ± 7.9 to 32.4 ± 8.9 in the CV-PLLA/β-TCP and the V-PLLA/β-TCP groups, respectively. New bone was formed in all the PLLA/β-TCP group at weeks 1 and 6.

Conclusions

CV- and V-PLLA/β-TCP composites controlled experimental IRO and promoted bone healing.

Clinical relevance

CV- and V-PLLA/β-TCP composites have the potential of controlling experimental IRO and promoting bone healing.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ozturan KE, Yucel I, Kocoglu E, Cakici H, Guven M: Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats. J Orthop Res. 2010, 28 (10): 1368-1372. 10.1002/jor.21159.CrossRefPubMed Ozturan KE, Yucel I, Kocoglu E, Cakici H, Guven M: Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats. J Orthop Res. 2010, 28 (10): 1368-1372. 10.1002/jor.21159.CrossRefPubMed
2.
go back to reference Zimmerli W: Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol. 2006, 20 (6): 1045-1063. 10.1016/j.berh.2006.08.003.CrossRefPubMed Zimmerli W: Infection and musculoskeletal conditions: prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol. 2006, 20 (6): 1045-1063. 10.1016/j.berh.2006.08.003.CrossRefPubMed
3.
go back to reference Orhan Z, Cevher E, Yıldız A, Ahıskalı R, Sensoy D, Mülazımoğlu L: Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Arch Orthop Trauma Surg. 2010, 130: 135-142. 10.1007/s00402-009-0886-9.CrossRefPubMed Orhan Z, Cevher E, Yıldız A, Ahıskalı R, Sensoy D, Mülazımoğlu L: Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis. Arch Orthop Trauma Surg. 2010, 130: 135-142. 10.1007/s00402-009-0886-9.CrossRefPubMed
4.
go back to reference Jiang JL, Li YF, Fang TL, Zhou J, Li XL, Wang YC, Dong J: Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits. Inflamm Res. 2012, 61 (3): 207-215. 10.1007/s00011-011-0402-x.CrossRefPubMed Jiang JL, Li YF, Fang TL, Zhou J, Li XL, Wang YC, Dong J: Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits. Inflamm Res. 2012, 61 (3): 207-215. 10.1007/s00011-011-0402-x.CrossRefPubMed
5.
go back to reference Li D, Gromov K, Søballe K, Puzas JE, O’Keefe RJ, Awad H, Drissi H, Schwarz EM: Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. J Orthop Res. 2008, 26 (1): 96-105. 10.1002/jor.20452.PubMedCentralCrossRefPubMed Li D, Gromov K, Søballe K, Puzas JE, O’Keefe RJ, Awad H, Drissi H, Schwarz EM: Quantitative mouse model of implant-associated osteomyelitis and the kinetics of microbial growth, osteolysis, and humoral immunity. J Orthop Res. 2008, 26 (1): 96-105. 10.1002/jor.20452.PubMedCentralCrossRefPubMed
6.
7.
go back to reference Yin LY, Calhoun JH, Thomas JK, Shapiro S, Schmitt-Hoffmann A: Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2008, 52 (5): 1618-1622. 10.1128/AAC.00638-07.PubMedCentralCrossRefPubMed Yin LY, Calhoun JH, Thomas JK, Shapiro S, Schmitt-Hoffmann A: Efficacies of ceftobiprole medocaril and comparators in a rabbit model of osteomyelitis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2008, 52 (5): 1618-1622. 10.1128/AAC.00638-07.PubMedCentralCrossRefPubMed
8.
go back to reference Fang T, Wen J, Zhou J, Shao Z, Dong J: Poly (ε-caprolactone) coating delays vancomycin delivery from porous chitosan/β-tricalcium phosphate composites. J Biomed Mater Res B Appl Biomater. 2012, 100 (7): 1803-1811. 10.1002/jbm.b.32747.CrossRefPubMed Fang T, Wen J, Zhou J, Shao Z, Dong J: Poly (ε-caprolactone) coating delays vancomycin delivery from porous chitosan/β-tricalcium phosphate composites. J Biomed Mater Res B Appl Biomater. 2012, 100 (7): 1803-1811. 10.1002/jbm.b.32747.CrossRefPubMed
9.
go back to reference Makarov C, Berdicevsky I, Raz-Pasteur A, Gotman I:In vitro antimicrobial activity of vancomycin-eluting bioresorbable β-TCP-polylactic acid nanocomposite material for load-bearing bone repair. J Mater Sci Mater Med. 2013, 24 (3): 679-687. 10.1007/s10856-012-4832-y.CrossRefPubMed Makarov C, Berdicevsky I, Raz-Pasteur A, Gotman I:In vitro antimicrobial activity of vancomycin-eluting bioresorbable β-TCP-polylactic acid nanocomposite material for load-bearing bone repair. J Mater Sci Mater Med. 2013, 24 (3): 679-687. 10.1007/s10856-012-4832-y.CrossRefPubMed
10.
go back to reference Park PI, Makoid M, Jonnalagadda S: The design of flexible ciprofloxacin-loaded PLGA implants using a reversed phase separation/coacervation method. Eur J Pharm Biopharm. 2011, 77 (2): 233-239. 10.1016/j.ejpb.2010.11.014.CrossRefPubMed Park PI, Makoid M, Jonnalagadda S: The design of flexible ciprofloxacin-loaded PLGA implants using a reversed phase separation/coacervation method. Eur J Pharm Biopharm. 2011, 77 (2): 233-239. 10.1016/j.ejpb.2010.11.014.CrossRefPubMed
11.
go back to reference Petrone C, Hall G, Langman M, Filiaggi MJ: Compaction strategies for modifying the drug delivery capabilities of gelled calcium polyphosphate matrices. Acta Biomater. 2008, 4 (2): 403-413. 10.1016/j.actbio.2007.09.007.CrossRefPubMed Petrone C, Hall G, Langman M, Filiaggi MJ: Compaction strategies for modifying the drug delivery capabilities of gelled calcium polyphosphate matrices. Acta Biomater. 2008, 4 (2): 403-413. 10.1016/j.actbio.2007.09.007.CrossRefPubMed
12.
go back to reference Ahola N, Männistö N, Veiranto M, Karp M, Rich J, Efimov A, Seppälä J, Kellomäki M: An in vitro study of composites of poly (L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis. Biomatter. 2013, 3 (2): 1-13. 10.4161/biom.23162.CrossRef Ahola N, Männistö N, Veiranto M, Karp M, Rich J, Efimov A, Seppälä J, Kellomäki M: An in vitro study of composites of poly (L-lactide-co-ε-caprolactone), β-tricalcium phosphate and ciprofloxacin intended for local treatment of osteomyelitis. Biomatter. 2013, 3 (2): 1-13. 10.4161/biom.23162.CrossRef
13.
go back to reference Korkusuz F, Korkusuz P, Ekşioğlu F, Gürsel İ, Hasırcı V:In vivo response to biodegradable controlled antibiotic release systems. J Biomed Mater Res. 2001, 55: 217-228. 10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y.CrossRefPubMed Korkusuz F, Korkusuz P, Ekşioğlu F, Gürsel İ, Hasırcı V:In vivo response to biodegradable controlled antibiotic release systems. J Biomed Mater Res. 2001, 55: 217-228. 10.1002/1097-4636(200105)55:2<217::AID-JBM1008>3.0.CO;2-Y.CrossRefPubMed
14.
go back to reference Gbureck U, Vorndran E, Barralet JE: Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditions. Acta Biomater. 2008, 4: 1480-1486. 10.1016/j.actbio.2008.02.027.CrossRefPubMed Gbureck U, Vorndran E, Barralet JE: Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditions. Acta Biomater. 2008, 4: 1480-1486. 10.1016/j.actbio.2008.02.027.CrossRefPubMed
15.
go back to reference Miyai T, Ito A, Tamazawa G, Matsuno T, Sogo Y, Nakamura C, Yamazaki A, Satoh T: Antibiotic-loaded poly-ε-caprolactone and porous β-tricalcium phosphate composite for treating osteomyelitis. Biomaterials. 2008, 29: 350-358. 10.1016/j.biomaterials.2007.09.040.CrossRefPubMed Miyai T, Ito A, Tamazawa G, Matsuno T, Sogo Y, Nakamura C, Yamazaki A, Satoh T: Antibiotic-loaded poly-ε-caprolactone and porous β-tricalcium phosphate composite for treating osteomyelitis. Biomaterials. 2008, 29: 350-358. 10.1016/j.biomaterials.2007.09.040.CrossRefPubMed
16.
go back to reference Luginbuehl V, Ruffieux K, Hess C, Reichardt D, von Rechenberg B, Nuss K: Controlled release of tetracycline from biodegradable β-tricalcium phosphate composites. J Biomed Mater Res B Appl Biomater. 2010, 92B: 341-352. Luginbuehl V, Ruffieux K, Hess C, Reichardt D, von Rechenberg B, Nuss K: Controlled release of tetracycline from biodegradable β-tricalcium phosphate composites. J Biomed Mater Res B Appl Biomater. 2010, 92B: 341-352.
17.
go back to reference Kankilic B, Bayramli E, Kilic E, Dağdeviren S, Korkusuz F: Vancomycin containing PLLA/β-TCP controls MRSA in vitro. Clin Ortop Relat Res. 2011, 469: 3222-3228. 10.1007/s11999-011-2082-9.CrossRef Kankilic B, Bayramli E, Kilic E, Dağdeviren S, Korkusuz F: Vancomycin containing PLLA/β-TCP controls MRSA in vitro. Clin Ortop Relat Res. 2011, 469: 3222-3228. 10.1007/s11999-011-2082-9.CrossRef
18.
go back to reference Korkusuz F, Uchida A, Shinto Y, Inoue K, Ono K: Biomaterial centered chronic osteomyelitis. Turk J Med Res. 1992, 10: 268-292. Korkusuz F, Uchida A, Shinto Y, Inoue K, Ono K: Biomaterial centered chronic osteomyelitis. Turk J Med Res. 1992, 10: 268-292.
19.
go back to reference Aktekin CN, Ozturk AM, Tabak AY, Altay M, Korkusuz F: A different perspective for radiological evaluation of experimental osteomyelitis. Skeletal Radiol. 2007, 36: 945-950. 10.1007/s00256-007-0342-2.CrossRefPubMed Aktekin CN, Ozturk AM, Tabak AY, Altay M, Korkusuz F: A different perspective for radiological evaluation of experimental osteomyelitis. Skeletal Radiol. 2007, 36: 945-950. 10.1007/s00256-007-0342-2.CrossRefPubMed
20.
go back to reference Petty W, Spanier S, Shuster JJ, Silverthorne C: The influence of skeletal implants on incidence of infection: experiment in a canine model. J Bone Joint Surg Am. 1985, 67: 1236-1244.PubMed Petty W, Spanier S, Shuster JJ, Silverthorne C: The influence of skeletal implants on incidence of infection: experiment in a canine model. J Bone Joint Surg Am. 1985, 67: 1236-1244.PubMed
21.
go back to reference Lawson MC, Hoth KC, Deforest CA, Bowman CN, Anseth KS: Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives. Clin Orthop Relat Res. 2010, 468 (8): 2081-2091. 10.1007/s11999-010-1266-z.PubMedCentralCrossRefPubMed Lawson MC, Hoth KC, Deforest CA, Bowman CN, Anseth KS: Inhibition of Staphylococcus epidermidis biofilms using polymerizable vancomycin derivatives. Clin Orthop Relat Res. 2010, 468 (8): 2081-2091. 10.1007/s11999-010-1266-z.PubMedCentralCrossRefPubMed
22.
go back to reference Klemm K: The use of antibiotic-containing bead chains in the treatment of chronic bone infections. Clin Microbiol Infect. 2001, 7: 28-31. 10.1046/j.1469-0691.2001.00186.x.CrossRefPubMed Klemm K: The use of antibiotic-containing bead chains in the treatment of chronic bone infections. Clin Microbiol Infect. 2001, 7: 28-31. 10.1046/j.1469-0691.2001.00186.x.CrossRefPubMed
23.
go back to reference Ozturk AM, Tabak AY, Aktekin CN, Altay M, Erdemli E, Karahuseyinoglu S, Korkusuz F: Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis. Int Orthop. 2008, 32: 821-827. 10.1007/s00264-007-0396-8.PubMedCentralCrossRefPubMed Ozturk AM, Tabak AY, Aktekin CN, Altay M, Erdemli E, Karahuseyinoglu S, Korkusuz F: Alendronate enhances antibiotic-impregnated bone grafts in the treatment of osteomyelitis. Int Orthop. 2008, 32: 821-827. 10.1007/s00264-007-0396-8.PubMedCentralCrossRefPubMed
24.
go back to reference Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Haas NP: Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone. 2003, 32 (5): 521-531. 10.1016/S8756-3282(03)00050-4.CrossRefPubMed Lucke M, Schmidmaier G, Sadoni S, Wildemann B, Schiller R, Haas NP: Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone. 2003, 32 (5): 521-531. 10.1016/S8756-3282(03)00050-4.CrossRefPubMed
25.
go back to reference Pihlajamäki H, Böstman O, Tynninen O, Laitinen O: Long-term tissue response to bioabsorbable poly-l-lactide and metallic screws: an experimental study. Bone. 2006, 39: 932-937. 10.1016/j.bone.2006.04.009.CrossRefPubMed Pihlajamäki H, Böstman O, Tynninen O, Laitinen O: Long-term tissue response to bioabsorbable poly-l-lactide and metallic screws: an experimental study. Bone. 2006, 39: 932-937. 10.1016/j.bone.2006.04.009.CrossRefPubMed
26.
go back to reference Cao L, Duan PG, Wang HR, Li XL, Yuan FL, Fan ZY, Li SM, Dong J: Degradation and osteogenic potential of a novel poly (lactic acid)/nano-sized β-tricalcium phosphate scaffold. Int J Nanomedicine. 2012, 7: 5881-5888. 10.2147/IJN.S38127.PubMedCentralCrossRefPubMed Cao L, Duan PG, Wang HR, Li XL, Yuan FL, Fan ZY, Li SM, Dong J: Degradation and osteogenic potential of a novel poly (lactic acid)/nano-sized β-tricalcium phosphate scaffold. Int J Nanomedicine. 2012, 7: 5881-5888. 10.2147/IJN.S38127.PubMedCentralCrossRefPubMed
27.
go back to reference Soundrapandian C, Sa B, Datta S: Organic-inorganic composites for bone drug delivery. AAPS PharmSciTech. 2009, 10 (4): 1158-1171. 10.1208/s12249-009-9308-0.PubMedCentralCrossRefPubMed Soundrapandian C, Sa B, Datta S: Organic-inorganic composites for bone drug delivery. AAPS PharmSciTech. 2009, 10 (4): 1158-1171. 10.1208/s12249-009-9308-0.PubMedCentralCrossRefPubMed
28.
go back to reference Baro M, Sanchez E, Delgado A, Perera A, Evora C:In vitro-in vivo characterization of gentamicin bone implants. J Control Release. 2002, 83: 353-364. 10.1016/S0168-3659(02)00179-7.CrossRefPubMed Baro M, Sanchez E, Delgado A, Perera A, Evora C:In vitro-in vivo characterization of gentamicin bone implants. J Control Release. 2002, 83: 353-364. 10.1016/S0168-3659(02)00179-7.CrossRefPubMed
Metadata
Title
Vancomycin containing PLLA/β-TCP controls experimental osteomyelitis in vivo
Authors
Berna Kankilic
Elif Bilgic
Petek Korkusuz
Feza Korkusuz
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2014
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-014-0114-3

Other articles of this Issue 1/2014

Journal of Orthopaedic Surgery and Research 1/2014 Go to the issue